Evidence Repository
The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!
  • No Criteria Specification was provided in the publication event for the variant classifaction.
  • The Criteria Specification shown below is a best-estimate based on the VCEP, gene, disease, and publication date.

Variant: NM_000038.6(APC):c.1627G>T (p.Val543Phe)

CA16024864

490221 (ClinVar)

Gene: APC (HGNC:324)
Condition: familial adenomatous polyposis 1 (MONDO:0021056)
Inheritance Mode: Autosomal dominant inheritance
UUID: 4b362109-ce61-450e-931e-aaa64c6a8657
Approved on: 2023-02-19
Published on: 2023-03-14

HGVS expressions

NM_000038.6(APC):c.1627G>T (p.Val543Phe)
NM_000038.6:c.1627G>T
NC_000005.10:g.112828856G>T
CM000667.2:g.112828856G>T
NC_000005.9:g.112164553G>T
CM000667.1:g.112164553G>T
NC_000005.8:g.112192452G>T
NG_008481.4:g.141336G>T
ENST00000257430.9:c.1627G>T
ENST00000257430.8:c.1627G>T
ENST00000502371.2:n.97-6095G>T
ENST00000504915.2:n.316G>T
ENST00000505084.1:n.114G>T
ENST00000507379.5:c.1573G>T
ENST00000508376.6:c.1627G>T
ENST00000508624.5:c.*949G>T
ENST00000512211.6:c.1627G>T
ENST00000520401.1:n.114G>T
NM_000038.5:c.1627G>T
NM_001127510.2:c.1627G>T
NM_001127511.2:c.1573G>T
NM_001354895.1:c.1627G>T
NM_001354896.1:c.1681G>T
NM_001354897.1:c.1657G>T
NM_001354898.1:c.1552G>T
NM_001354899.1:c.1543G>T
NM_001354900.1:c.1504G>T
NM_001354901.1:c.1450G>T
NM_001354902.1:c.1354G>T
NM_001354903.1:c.1324G>T
NM_001354904.1:c.1249G>T
NM_001354905.1:c.1147G>T
NM_001354906.1:c.778G>T
NM_001127510.3:c.1627G>T
NM_001127511.3:c.1573G>T
NM_001354895.2:c.1627G>T
NM_001354896.2:c.1681G>T
NM_001354897.2:c.1657G>T
NM_001354898.2:c.1552G>T
NM_001354899.2:c.1543G>T
NM_001354900.2:c.1504G>T
NM_001354901.2:c.1450G>T
NM_001354902.2:c.1354G>T
NM_001354903.2:c.1324G>T
NM_001354904.2:c.1249G>T
NM_001354905.2:c.1147G>T
NM_001354906.2:c.778G>T
More

Uncertain Significance

Met criteria codes 3
BP1 PM2_Supporting PS3_Moderate
Not Met criteria codes 2
PS4 PP3

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
InSiGHT Hereditary Colorectal Cancer/Polyposis VCEP
The c.1627G>T variant in APC is a missense variant predicted to cause a substitution of valine by phenylalanine at amino acid position 543 (p.Val543Phe). This variant is located at the first base of exon 14. RT-PCR of the exons flanking the target site in a patient with AFAP shows that the variant c.1627G>T impacts splicing by leading to exon 14 skipping, which is an in-frame event (PS3_Moderate; PMID22987206). This variant scored 0.5 phenotype points based on information available in 3 individuals (PS4_variable not met; PMID 22987206, Invitae internal data). This variant is absent from gnomAD v2.1.1 (PM2_supporting). In silico predictions by SpliceAI, MaxEntScan and VarSEAK showed conflicting results (PP3 not met). APC is defined by the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel (HCCP VCEP) as a gene for which primarily truncating variants are known to cause disease (BP1). In summary, this is a Variant of Uncertain Significance (VUS) for FAP based on the ACMG/AMP criteria applied, as specified by the HCCP VCEP: BP1, PS3_moderate, and PM2_supporting. (VCEP specifications version 1; date of approval: 12/12/2022).
Met criteria codes
BP1
APC, in which the variant was identified, is defined by the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis VCEP as a gene for which primarily truncating variants are known to cause disease (BP1).
PM2_Supporting
This variant is absent from gnomAD v2.1.1 (PM2_supporting).
PS3_Moderate
RT-PCR of exons flanking the target site in a patient with AFAP showed that the variant c.1627G>T impacts splicing by leading to exon 13 skipping (PMID22987206)(PS3_moderate).
Not Met criteria codes
PS4
0.5 points based on phenotype information available in 3 individuals (PS4 not met, PMID 2298720, Invitae internal data).
PP3
varSEAK predicts class 5 slicing effect (16.38% that authentic splice site will be ineffective), MaxEntScan 4.43 (difference -1.86), SpliceAI showed no impact on splicing (0.01 for acceptor loss).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.